| Drug Type Small molecule drug | 
| Synonyms Glubes, Mitiglinide/voglibose, Voglibose/mitiglinide + [3] | 
| Action inhibitors, blockers | 
| Mechanism MGAM inhibitors(Maltase-glucoamylase inhibitors), Potassium channel blockers, VGKCs blockers(Voltage-gated potassium channel blockers) | 
| Therapeutic Areas | 
| Active Indication | 
| Inactive Indication- | 
| Originator Organization | 
| Active Organization | 
| Inactive Organization- | 
| License Organization- | 
| Drug Highest PhaseApproved | 
| First Approval Date Japan (22 Apr 2011),  | 
| Regulation- | 
| Molecular FormulaC10H21NO7 | 
| InChIKeyFZNCGRZWXLXZSZ-CIQUZCHMSA-N | 
| CAS Registry83480-29-9 | 
| KEGG | Wiki | ATC | Drug Bank | 
|---|---|---|---|
| - | - | - | 
| Indication | Country/Location | Organization | Date | 
|---|---|---|---|
| Diabetes Mellitus, Type 2 | Japan  | 22 Apr 2011 | 





